Allelic variation in CRHR 1 predisposes to panic disorder by biasing towards fear

Corticotropin releasing hormone (CRH) is a major regulator of the hypothalamicpituitary-adrenal (HPA) axis. Binding to its receptor CRHR1 triggers the downstream release of cortisol, a hormone needed for regulation of stress responses. Biochemical, behavioral and genetic studies revealed CRHR1 as a possible candidate gene for mood and anxiety disorders. Here, we aimed to evaluate CRHR1 as a candidate molecule in panic disorder (PD). Allelic variation throughout the CRHR1 gene was captured by 9 selected single nucleotide polymorphisms (SNPs); these were genotyped in 531 matched case/control pairs (discovery sample (n=239); replication sample (n=292)). Four SNPs were found to be associated with PD, in at least one sub-sample. The minor alleles of rs17689918 and rs17689966 were found to significantly increase risk for PD in females of the discovery, the replication and the combined sample, both withstanding correction for multiple testing (prs17689918=1.3*10 ; prs17689966=0.042). Expressional analysis demonstrated that both minor alleles of rs17689918 and rs17689966 significantly decreased CRHR1 mRNA in the forebrain and amygdala. Bioinformatical analysis revealed a high proportion of differential neuro-relevant transcription factor binding possibly underlying expression changes. When investigating the neural correlates underlying this association, risk allele carriers of rs17689918 and rs17689966 showed aberrant differential conditioning and safety signal processing arguing for predominant generalization of fear and hence anxious apprehension. Furthermore, the minor risk (A) allele of rs17689918 led to less flight behavior during fear provoking situations, but rather increased anxious apprehension and went along with increased anxiety sensitivity. Thus, reduced CRHR1 expression driven by CRHR1 risk allele leads to a phenotype characterized by a fear bias and hence sustained fear. These results strengthen the role of CRHR1 in PD and clarify the mechanisms by which genetic variation in CRHR1 is linked to this disorder.

[1]  C. Freitag,et al.  The genetic contribution of the NO system at the glutamatergic post-synapse to schizophrenia: Further evidence and meta-analysis , 2014, European Neuropsychopharmacology.

[2]  M. Kanehisa,et al.  Association between corticotropin-releasing hormone receptor 1 and 2 (CRHR1 and CRHR2) gene polymorphisms and personality traits , 2013, Psychiatric genetics.

[3]  A. Jansen,et al.  Neural substrates of treatment response to cognitive-behavioral therapy in panic disorder with agoraphobia. , 2013, The American journal of psychiatry.

[4]  Vladimir I. Vladimirov,et al.  Association of CRHR1 variants and posttraumatic stress symptoms in hurricane exposed adults. , 2013, Journal of anxiety disorders.

[5]  Pedro G. Ferreira,et al.  Transcriptome and genome sequencing uncovers functional variation in humans , 2013, Nature.

[6]  R. Oosting,et al.  Human Fear Acquisition Deficits in Relation to Genetic Variants of the Corticotropin Releasing Hormone Receptor 1 and the Serotonin Transporter , 2013, PloS one.

[7]  Martin H. Schmidt,et al.  Interactive effects of corticotropin-releasing hormone receptor 1 gene and childhood adversity on depressive symptoms in young adults: Findings from a longitudinal study , 2013, European Neuropsychopharmacology.

[8]  A. Jansen,et al.  Altered top-down and bottom-up processing of fear conditioning in panic disorder with agoraphobia , 2013, Psychological Medicine.

[9]  Wanhong Liu,et al.  Negative life events and corticotropin-releasing-hormone receptor1 gene in recurrent major depressive disorder , 2013, Scientific Reports.

[10]  A. Gloster,et al.  Effect of Cognitive-Behavioral Therapy on Neural Correlates of Fear Conditioning in Panic Disorder , 2013, Biological Psychiatry.

[11]  G. Alpers,et al.  Meta‐analysis argues for a female‐specific role of MAOA‐uVNTR in panic disorder in four European populations , 2012, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[12]  A. Gloster,et al.  Dynamics of Defensive Reactivity in Patients with Panic Disorder and Agoraphobia: Implications for the Etiology of Panic Disorder , 2012, Biological Psychiatry.

[13]  F. Holsboer,et al.  Early‐life stress‐induced anxiety‐related behavior in adult mice partially requires forebrain corticotropin‐releasing hormone receptor 1 , 2012, The European journal of neuroscience.

[14]  S. Langenecker,et al.  Variation in the Corticotropin-Releasing Hormone Receptor 1 (CRHR1) Gene Influences fMRI Signal Responses during Emotional Stimulus Processing , 2012, The Journal of Neuroscience.

[15]  F. Holsboer,et al.  Consolidation of Remote Fear Memories Involves Corticotropin-Releasing Hormone (CRH) Receptor Type 1-Mediated Enhancement of AMPA Receptor GluR1 Signaling in the Dentate Gyrus , 2012, Neuropsychopharmacology.

[16]  David L. Walker,et al.  EFFECTS OF CONTINUOUSLY ENHANCED CORTICOTROPIN RELEASING FACTOR EXPRESSION WITHIN THE BED NUCLEUS OF THE STRIA TERMINALIS ON CONDITIONED AND UNCONDITIONED ANXIETY , 2012, Molecular Psychiatry.

[17]  L. Farrer,et al.  A CRHR1 haplotype moderates the effect of adverse childhood experiences on lifetime risk of major depressive episode in African‐American women , 2011, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[18]  E. V. van Rossum,et al.  Glucocorticoid Sensitivity in Mood Disorders , 2011, Neuroendocrinology.

[19]  M. Bradley,et al.  Aversive Imagery in Panic Disorder: Agoraphobia Severity, Comorbidity, and Defensive Physiology , 2011, Biological Psychiatry.

[20]  A. Gloster,et al.  Neuropeptide S receptor gene — converging evidence for a role in panic disorder , 2011, Molecular Psychiatry.

[21]  D. Cicchetti,et al.  Moderation of the association between childhood maltreatment and neuroticism by the corticotropin-releasing hormone receptor 1 gene. , 2011, Journal of child psychology and psychiatry, and allied disciplines.

[22]  U. John,et al.  Moderation of Adult Depression by a Polymorphism in the FKBP5 Gene and Childhood Physical Abuse in the General Population , 2011, Neuropsychopharmacology.

[23]  F. Holsboer,et al.  Forebrain CRHR1 deficiency attenuates chronic stress-induced cognitive deficits and dendritic remodeling , 2011, Neurobiology of Disease.

[24]  P. Moorjani,et al.  Corticotrophin-Releasing Hormone Type 1 Receptor Gene (CRHR1) Variants Predict Posttraumatic Stress Disorder Onset and Course in Pediatric Injury Patients , 2011, Disease markers.

[25]  W. Rathmann,et al.  Cohort profile: the study of health in Pomerania. , 2011, International journal of epidemiology.

[26]  U. John,et al.  Childhood maltreatment, the corticotropin‐releasing hormone receptor gene and adult depression in the general population , 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[27]  A. Thorsell.  Brain neuropeptide Y and corticotropin-releasing hormone in mediating stress and anxiety , 2010, Experimental biology and medicine.

[28]  A. Jansen,et al.  Neural correlates of aversive conditioning: development of a functional imaging paradigm for the investigation of anxiety disorders , 2010, European Archives of Psychiatry and Clinical Neuroscience.

[29]  Elisabeth B Binder,et al.  Polymorphisms in CRHR1 and the Serotonin Transporter Loci: Gene × Gene × Environment Interactions on Depressive Symptoms , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[30]  M. Davis,et al.  Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus phasic fear-like responses , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[31]  M. Höfler,et al.  Mechanism of action in CBT (MAC): methods of a multi-center randomized controlled trial in 369 patients with panic disorder and agoraphobia , 2009, European Archives of Psychiatry and Clinical Neuroscience.

[32]  A. Caspi,et al.  Protective effect of CRHR1 gene variants on the development of adult depression following childhood maltreatment: replication and extension. , 2009, Archives of general psychiatry.

[33]  B. Bradley,et al.  Effect of Childhood Trauma on Adult Depression and Neuroendocrine Function: Sex-Specific Moderation by CRH Receptor 1 Gene , 2009, Front. Behav. Neurosci..

[34]  C. Béroud,et al.  Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.

[35]  D. Wasserman,et al.  Depression in suicidal males: genetic risk variants in the CRHR1 gene , 2009, Genes, brain, and behavior.

[36]  M. Weissman,et al.  Association and linkage analysis of candidate genes GRP, GRPR, CRHR1, and TACR1 in panic disorder , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[37]  W. Maier,et al.  Combined effects of exonic polymorphisms in CRHR1 and AVPR1B genes in a case/control study for panic disorder , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[38]  Philip S Rosenberg,et al.  PGA: power calculator for case-control genetic association analyses , 2008, BMC Genetics.

[39]  Florian Holsboer,et al.  Central CRH system in depression and anxiety--evidence from clinical studies with CRH1 receptor antagonists. , 2008, European journal of pharmacology.

[40]  Michel Georges,et al.  Patrocles: a database of polymorphic miRNA-mediated gene regulation in vertebrates , 2008, Nucleic Acids Res..

[41]  K. Ressler,et al.  Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. , 2008, Archives of general psychiatry.

[42]  Zhaohui S. Qin,et al.  A second generation human haplotype map of over 3.1 million SNPs , 2007, Nature.

[43]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[44]  D. Wasserman,et al.  The CRHR1 gene: a marker for suicidality in depressed males exposed to low stress , 2007, Genes, brain, and behavior.

[45]  Florian Holsboer,et al.  CRF signaling: molecular specificity for drug targeting in the CNS. , 2006, Trends in pharmacological sciences.

[46]  Z. Cao,et al.  Association of corticotropin-releasing hormone receptor1 gene SNP and haplotype with major depression , 2006, Neuroscience Letters.

[47]  J. Schulkin,et al.  A neuroendocrine mechanism for sustaining fear , 2005, Trends in Neurosciences.

[48]  Thomas Werner,et al.  MatInspector and beyond: promoter analysis based on transcription factor binding sites , 2005, Bioinform..

[49]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[50]  K. Catt,et al.  Corticotropin releasing hormone receptors: two decades later , 2004, Peptides.

[51]  F. Holsboer,et al.  Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress , 2003, Nature Neuroscience.

[52]  J. Hart,et al.  Distinct prefrontal cortex activity associated with item memory and source memory for visual shapes. , 2003, Brain research. Cognitive brain research.

[53]  A. Moorman,et al.  Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data , 2003, Neuroscience Letters.

[54]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[55]  F. Holsboer,et al.  Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1 , 1998, Nature Genetics.

[56]  A. Farmer,et al.  The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures. , 1988, Archives of general psychiatry.

[57]  A. Hamm,et al.  When the threat comes from inside the body: a neuroscience based learning perspective of the etiology of panic disorder. , 2014, Restorative neurology and neuroscience.

[58]  石飛 佳宣.  Association of CRHR1 and CRHR2 with major depressive disorder and panic disorder in a Japanese population , 2013 .

[59]  C. Grillon,et al.  Overgeneralization of conditioned fear as a pathogenic marker of panic disorder. , 2010, The American journal of psychiatry.

[60]  C. Grillon,et al.  Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety , 2010, Neuropsychopharmacology.

[61]  Florian Holsboer,et al.  Stress hormone regulation: biological role and translation into therapy. , 2010, Annual review of psychology.

[62]  D. Swaab,et al.  Corticotropin-releasing hormone and arginine vasopressin in depression focus on the human postmortem hypothalamus. , 2010, Vitamins and hormones.

[63]  D. Bernstein,et al.  Childhood Trauma Questionnaire: A retrospective self-report , 1998 .

[64]  S. Reiss,et al.  Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. , 1986, Behaviour research and therapy.

[65]  D. Klein,et al.  Schedule for Affective Disorders and Schizophrenia--Lifetime Version modified for the study of anxiety disorders (SADS-LA): rationale and conceptual development. , 1986, Journal of psychiatric research.

[66]  D. Chambless,et al.  Assessment of fear of fear in agoraphobics: the body sensations questionnaire and the agoraphobic cognitions questionnaire. , 1984, Journal of consulting and clinical psychology.